Creative Biolabs-Immuno-oncology

Anti-KLK3 (clone C9Q-B) SynExpress T7-R-I4-H Modified CD8+ T cells (CAT#: ITS-1224-CR993)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target KLK3 (clone C9Q-B). We employs the HBV (T7-RFP-IL-4-HindIII) vector components and the SynExpress system of the Introns Substitution/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
KLK3
Clone
C9Q-B
Species Reactivity
Mouse
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
T7
Effector Gene
IL-4
Insertion Sites
HindIII
Gene Modification
Substitution
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.89
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.